Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Unichem Laboratories Limited ( (IN:UNICHEMLAB) ) has shared an announcement.
Unichem Laboratories has announced the results of a postal ballot in which shareholders approved all resolutions put to remote e-vote, including the appointment of Dr. Swati Patankar as a non-executive independent director for a five-year term starting 5 February 2026. The ballot also cleared material related-party transactions between parent Ipca Laboratories, Unichem and its U.S. subsidiary Unichem Pharmaceuticals USA Inc., with near-unanimous support from voting shareholders, reinforcing governance of group dealings and enabling continued intra-group business flows.
Remote e-voting saw about 80.5% of Unichem’s share capital participate, with almost 100% of votes cast in favour of the resolutions, indicating strong shareholder backing for the refreshed board composition and cross-border related-party arrangements. The approval secures regulatory compliance under listing norms for significant related-party transactions and provides clarity to stakeholders on the company’s governance framework and operational alignment within the Ipca-Unichem group structure.
More about Unichem Laboratories Limited
Unichem Laboratories Limited is an Indian pharmaceutical company engaged in the development, manufacture and marketing of formulations and active pharmaceutical ingredients. The group operates in domestic and international markets, including the U.S. through its wholly owned subsidiary Unichem Pharmaceuticals USA Inc., and is part of the Ipca Laboratories group following its acquisition.
Average Trading Volume: 4,346
Technical Sentiment Signal: Sell
Current Market Cap: 19.98B INR
Find detailed analytics on UNICHEMLAB stock on TipRanks’ Stock Analysis page.